Government caps trade margins on 137 anti-cancer drugs at 30%

The government has set a ceiling of 30% on trade margins for 137 anti-cancer medicines. The move is aimed at making these life-saving drugs more affordable for patients. The cap restricts how much profit intermediaries can add to the price of these medicines. Officials framed the step as a measure to ease the financial burden of cancer treatment on households.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.

Discussion (0)
Log in to join the discussion and vote.
Log in